## APPN: Appian Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.12 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($34.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 9 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+13.0%)
- Blackrock Inc.: 8.0% (+6.7%)
- Lead Edge Capital Ma: 4.2% (+11.5%)
- Abdiel Capital Advis: 3.1% (-82.8%)
- Arrowstreet Capital,: 3.0% (+86.9%)

### Key Risks

1. Elevated short interest (8.7%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.12 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.8B |
| Beta | 0.85 |
| 52W Range | $24.00 - $46.06 |
| Short Interest | 8.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.12 |
| Forward P/E | 48.6 |
| Current P/E | 69.0 |
| YoY Growth | 42.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -9.6% to -5.8% (+3.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 9.8pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. AM_20 at -5.2% indicates price below own 20MA trend. Underperforming sector by 6.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.18x) but short-term weakness (below SMA20). MACD histogram bearish (-0.65), momentum weakening. RSI neutral at 46. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.79% (CS: 6) | Weak |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | -0.65 | Bearish |
| vs SMA20 | 0.947x | Below |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 1.181x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $37.40
- **Stop Loss:** $34.22 (8.5% risk)
- **Target:** $43.76 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 377
- **Position Value:** $14,099.80
- **Portfolio %:** 14.10%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-18 (Est: $0.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.32 | +490.0% |
| 2025Q2 | $-0.13 | $0.00 | +103.0% |
| 2025Q1 | $0.03 | $0.13 | +315.7% |
| 2024Q4 | $-0.01 | $0.00 | +100.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*